US 9820952
Solid solution compositions and use in chronic inflammation
granted A61KA61K31/12A61K31/121
Quick answer
US patent 9820952 (Solid solution compositions and use in chronic inflammation) held by Infirst Healthcare Limited expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Infirst Healthcare Limited
- Grant date
- Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/12, A61K31/121, A61K31/192, A61K31/196